Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 1
Journal homepage
2,940
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients

Masayoshi HarigaiDivision of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; Correspondence[email protected]
,
Tsuyoshi TsuchiyaMedical, AbbVie GK, Tokyo, Japan
,
Katsuyoshi KawanaMedical, AbbVie GK, Tokyo, Japan
&
Sarina KurimotoMedical, AbbVie GK, Tokyo, Japan
Pages 30-38 | Received 04 Oct 2016, Accepted 03 Mar 2017, Published online: 07 Apr 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nobunori Takahashi, Toshihisa Kojima, Daihei Kida, Atsushi Kaneko, Yuji Hirano, Takayoshi Fujibayashi, Yuichiro Yabe, Hideki Takagi, Takeshi Oguchi, Masahiro Hanabayashi, Takefumi Kato, Koji Funahashi, Masatoshi Hayashi, Seiji Tsuboi, Yasuhide Kanayama, Yasumori Sobue, Nobuyuki Asai, Takuya Matsumoto, Tatsuo Watanabe, Shuji Asai & Naoki Ishiguro. (2019) Clinical effectiveness and long-term retention of abatacept in elderly rheumatoid arthritis patients: Results from a multicenter registry system. Modern Rheumatology 29:6, pages 910-918.
Read now

Articles from other publishers (5)

Masataka Kuwana, Naonobu Sugiyama, Shigeki Momohara, Tatsuya Atsumi, Syuji Takei, Naoto Tamura, Masayoshi Harigai, Takao Fujii, Hiroaki Matsuno, Tsutomu Takeuchi, Kazuhiko Yamamoto, Yoshinari Takasaki, Miki Tanigawa, Yutaka Endo, Tomohiro Hirose, Yosuke Morishima, Noritoshi Yoshii, Tsuneyo Mimori & Michiaki Takagi. (2023) Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance. Modern Rheumatology.
Crossref
Sandra Rodríguez, Andrés Muñoz, Rosa-Helena Bustos & Diego Jaimes. (2020) Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines 8:9, pages 303.
Crossref
Shuzo Yoshida & Yuko Kimura. (2020) Successful treatment of adalimumab for older Behçet's disease complicated with pulmonary artery thrombosis: A case report. International Journal of Rheumatic Diseases 23:6, pages 837-839.
Crossref
Kwi Suk Kim, Young Hee Choi, Aree Moon & Sang Geon Kim. (2020) Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital Setting. Journal of Clinical Medicine 9:2, pages 461.
Crossref
. (2018) Adalimumab. Reactions Weekly 1691:1, pages 18-18.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.